Non-invasive Brain Stimulation

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
Closed-loop Non-invasive Brain StiumlationN/A1 trial
Active Trials
NCT06600217Not Yet Recruiting60Est. Sep 2027

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
LabcorpClosed-loop Non-invasive Brain Stiumlation

Clinical Trials (1)

Total enrollment: 60 patients across 1 trials

NCT06600217LabcorpClosed-loop Non-invasive Brain Stiumlation

Closed-loop Non-invasive Brain Stiumlation

Start: Oct 2024Est. completion: Sep 202760 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space